Browse Related Topics For:

Generic Drugs

198
Pharmaceutical
169
Patents
152
Pharmaceutical Manufacturers
148
Prescription Drugs
114
FDA
109
Pharmaceutical Patents
99
ANDA
83
Patent Infringement
82
Patent Litigation
73
Hatch-Waxman
64
SCOTUS
59
Drug Manufacturers
59
FTC
49
Reverse Payment Settlement Agreements
48
FTC v Actavis
45
Pay-For-Delay
39
Actavis Inc.
29
Antitrust Litigation
29
Preemption
24
Biosimilars
19
FDCA
19
Labeling
19
Teva Pharmaceuticals
17
Healthcare
16
Infringement
16
Medical Devices
15
Design Defects
15
Manufacturers
14
Appeals
14
Failure To Warn
14
Mylan Pharmaceuticals
14
Settlement
13
Popular
13
Sandoz
12
Antitrust Provisions
12
Biotechnology
12
Product Hopping
12
Sherman Act
11
AstraZeneca
11
BPCIA
11
Prior Art
11
Warning Labels
10
DOJ
10
Mutual Pharmaceuticals v Bartlett
10
Novartis
10
Watson Pharmaceuticals
9
Cephalon
9
EU
9
Preliminary Injunctions
8
Class Action
8
FDA Approval
8
Inter Partes Review Proceedings
8
OIG
8
Patent Trial and Appeal Board
8
Trademarks
7
Anti-Competitive
7
Apotex
7
CA Supreme Court
7
Corporate Counsel
7
Medicaid
7
Reverse Payments
7
Rule-of-Reason Analysis
7
USPTO
6
Affordable Care Act
6
America Invents Act
6
Antitrust Investigations
6
Bayer
6
China
6
Government Investigations
6
HHS
6
Jurisdiction
6
Merck
6
Obviousness
6
Orange Book
6
Orphan Drugs
6
Otsuka Pharmaceutical
6
Patent Applications
6
Pfizer
6
PLIVA v Mensing
6
RanBaxy
6
Sandoz v Amgen
5
Amgen
5
Cipro
5
Competition
5
GlaxoSmithKline
5
Medicare
5
Misrepresentation
5
Patent Invalidity
5
Pharmacies
4
Brand
4
Claim Construction
4
DaimlerAG
4
Declaratory Judgments
4
Eli Lilly
4
Hedge Funds
4
Intellectual Property Litigation
4
Liability
4
Life Sciences
4
Mensing
4
Nexium
4
Professional Conferences
4
Safe Harbors
4
Subpoenas
4
Wyeth
3
AbbVie
3
Abuse of Process
3
Antitrust Division
3
Antitrust Violations
3
Biologics
3
Biologics Price Competition and Innovation Act of 2009
3
Cartels
3
Cartwright Act
3
Classen Immunotherapies
3
Clinical Trials
3
CMS
3
Compliance
3
Duty to Deal
3
European Commission
3
False Claims Act
3
First Sale Doctrine
3
GDUFA
3
Generic
3
Healthcare Reform
3
Hoffman LaRoche
3
Hospitals
3
Innovation
3
Innovator Liability
3
Johnson & Johnson
3
Medicare Part D
3
Monopolization
3
On-Sale Bar
3
Par Pharmaceutical
3
Patent-Eligible Subject Matter
3
Personal Jurisdiction
3
Post-Grant Review
3
Putative Class Actions
3
Summary Judgment
3
Unfair Competition
2
Abbott Laboratories
2
Acquisitions
2
Allergan Inc
2
Amarin
2
Anticompetitive Agreements
2
Antitrust Conspiracies
2
Attorney Generals
2
Australia
2
Canada
2
Chevron Deference
2
Citizen Petitions
2
Civil Monetary Penalty
2
Commercial Marketing
2
Consent Order
2
Copyright
2
Covered Business Method Patents
2
DaimlerChrysler v Bauman
2
Disclosure
2
Disgorgement
2
Dismissals
2
Drug Safety
2
Durable Medical Equipment
2
Elan Pharmaceuticals
2
Enforcement Actions
2
Exclusivity
2
Exports
2
Federal Question Jurisdiction
2
Food Safety
2
Foreign Manufacturers
2
Fraud
2
Fresenius
2
Gilead Sciences
2
Google
2
Health Insurance
2
Injunctions
2
INTERPOL
2
Japan
2
Jazz Pharmaceuticals
2
Licenses
2
Manufacturing Defects
2
Marketing
2
Medicare Modernization Act
2
Minimum Contacts
2
Motion to Dismiss
2
Multinationals
2
New Guidance
2
NIH
2
Noninfringement
2
Notice Requirements
2
Nursing Homes
2
Octane Fitness v. ICON
2
Off-Label Promotion
2
Patent Dance
2
Patent Owner Preliminary Response
2
Permanent Injunctions
2
Presumption of Validity
2
Price-Fixing
2
Prilosec
2
Product Exclusivity
2
Product Labels
2
Proposed Legislation
2
Proposed Regulation
2
Qui Tam
2
Real Party in Interest
2
Recordkeeping Requirements
2
Restraint of Trade
2
Reversal
2
Settlement Agreements
2
SmithKline Beecham
2
Software
2
Standing
2
Strategic Enforcement Plan
2
Takeda Pharmaceuticals
2
Teva v Sandoz
2
The Clayton Act
2
TRO
2
Websites
2
Whistleblowers
1
21st Century Cures Initiative
1
aBLA
1
Abuse of Dominance
1
ACOs
1
Advance Notice
1
Advertising
1
AL Supreme Court
1
Alien Tort Statute
1
Allergan v Sandoz
1
Ambiguous
1
Amended Complaints
1
Amnesty
1
AMP v Myriad
1
Anti-Corruption
1
Anti-Kickback Statute
1
Anticompetitive Behavior
1
Antitrust Injuries
1
Approval
1
Asia Pacific
1
Assignments
1
Australian Competition and Consumer Commission
1
Auto Parts
1
Automotive Industry
1
Aviation Industry
1
Bad Debt
1
Barack Obama
1
Barclays
1
Best Practices
1
Biogen Idec
1
Biopharmaceutical
1
Bipolar Disorder
1
Birth Defects
1
Boehringer
1
Boeing
1
Books
1
Bowman v Monsanto
1
BPCI
1
Brazil
1
Breach of Warranty
1
Bribery
1
Burden of Proof
1
Burden-Shifting
1
Cadence Pharmaceuticals Inc.
1
Carve Out Provisions
1
CDC
1
CFDA
1
Charitable PAPs
1
Cisco v CommilUSA
1
Clear and Convincing Evidence
1
Clearance
1
Comment Period
1
Competition Act
1
Competition Authorities
1
Complex Litigation
1
Congressional Investigations & Hearings
1
Contraceptive Coverage Mandate
1
Contraceptives
1
Copyright Infringement
1
Corrective Actions
1
Corruption
1
Cost-Sharing
1
Counterfeit Drugs
1
Counterfeiting
1
Covenant Not to Sue
1
Covered Business Method Proceedings
1
CPSC
1
Criminal Antitrust Litigation
1
Daiichi Sankyo
1
Data Breach
1
Data Protection
1
De Novo Standard of Review
1
Defect
1
Deficit Reduction
1
Design Patent
1
DHS
1
Diagnostic Tests
1
Dietary Supplements
1
Direct Purchasers
1
Directed Verdicts
1
Disparagement
1
Distributors
1
Diversity Jurisdiction
1
Divisional Applications
1
Doctrine of Equivalents
1
DOHA
1
DQSA
1
Draft Guidance
1
Drug Approvals
1
Drug Compounding
1
Drug Distribution
1
Drug Pricing
1
DSCSA
1
Duty to Warn
1
EAR
1
Edith Ramirez
1
EHR
1
Email
1
Endo Pharmaceuticals
1
Energy Sector
1
Enforcement
1
Entertainment Industry
1
Exceptional Case
1
Expert Testimony
1
Extraterritoriality Rules
1
FAA
1
False Advertising
1
FDA Warning Letters
1
FDASIA
1
Federal Budget
1
Federal Jurisdiction
1
Federal Rule 12(b)(6)
1
Federal Trade Commission Act
1
Final Rules
1
Fines
1
First Amendment
1
Food Contamination
1
Food Labeling
1
Food Recalls
1
Foreign Corporations
1
Foreign Exchanges
1
Foreign Trade Regulations
1
Forest Laboratories
1
Form 8-K
1
Forum
1
Forum Non Conveniens
1
Forum Shopping
1
FRAND
1
Fraud and Abuse
1
Fraudulent Procurement
1
Free Speech
1
FTCA
1
Genentech
1
Genetically Engineered Seed
1
Goodyear
1
Grable Factors
1
Grand Juries
1
Health Information Technologies
1
Highmark
1
Highmark v. Allcare
1
Honeywell International
1
Hospital Mergers
1
Hotels
1
Human Genes
1
Imports
1
India
1
Indirect Purchasers
1
Induced Infringement
1
Information Disclosure Statement
1
Information Reports
1
Informed Consent
1
Innovation Act
1
Inspections
1
Inspector General
1
Insurers
1
Intellectual Property Protection
1
Intent-to-Use
1
Interest Rates
1
International Arbitration
1
International Treaties
1
Inventions
1
Inventors
1
IPR
1
IRF Claim Processing
1
Irreparable Harm
1
IRS
1
ITC
1
Janssen Pharmaceuticals
1
Judges
1
Jury Awards
1
Jury Verdicts
1
Justiciable Controversy
1
Kickbacks
1
King v Burwell
1
Kirtsaeng v. John Wiley & Sons
1
Laches
1
Lanham Act
1
Legislative Agendas
1
Libor
1
License Agreements
1
Licensing Rules
1
Lipitor
1
Loss Causation
1
Material Defects
1
Media
1
Medical Research
1
Medicare Advantage
1
MedPAC
1
Medtronic
1
Medtronics
1
Mergers
1
Ministry of Health
1
Mistrial
1
Monsanto
1
Mootness
1
Motion for Sanctions
1
Motorola
1
Myriad
1
Native American Issues
1
New Legislation
1
New Regulations
1
Nike
1
No-AG Agreement
1
Non-Compete Agreements
1
Non-Grandfathered Health Plans
1
Notifications
1
Nutritional Supplements
1
Omnicare
1
Online Drug Sales
1
OTDP
1
Out-of-State Companies
1
OxyContin
1
Patent Assertion Entities
1
Patent Exhaustion
1
Patent Prosecution
1
Patent Reform
1
Patent Term Adjustment
1
Patent Term Extensions
1
Patent-in-Suit
1
Patentability Search
1
Patient Self-Referral
1
Patients
1
Pay-to-Delay System
1
PHRMA
1
Physician Payments
1
Pleading Standards
1
Premarket Approval Applications
1
Prescription Drug Plans
1
Pretext
1
Private Right of Action
1
Proctor & Gamble
1
Proposed Amendments
1
Public Disclosure
1
Public Meetings
1
Public Performance Rights
1
Rare Earth Metals
1
Rebates
1
Registration
1
Registration Requirement
1
Regulatory Agenda
1
Reissue Patents
1
REMS
1
Restraining Orders
1
Risk Assessment
1
Risk Management
1
Risk Mitigation
1
Roxane Laboratories
1
Rule 11
1
Rulemaking Process
1
Safety Precautions
1
Sales Contracts
1
Schering-Plough
1
SEC
1
Section 2
1
SFDA
1
Shell Oil
1
Shire Development v Watson
1
SNDAs
1
Specific Jurisdiction
1
Spectrum
1
Sponsors
1
Sports
1
Standard Essential Patents
1
Standard of Proof
1
Standard of Review
1
Standing Objections
1
State Law Tort Claims
1
Stem cells
1
Stocks
1
Structured Financial Products
1
Subject Matter Jurisdiction
1
Supplementary Protection Certificate
1
Supply Chain
1
Tax Credits
1
Textbooks
1
Trade Secrets
1
Trademark Application
1
Trademark Searches
1
Trans-Pacific Partnership
1
Transfer of Title
1
Transfer of Venue
1
TRIPS Agreement
1
Twombly/Iqbal Pleading Standard
1
UK
1
Unfair Pricing
1
Unjust Enrichment
1
Vacated
1
Vaccinations
1
Veterinary Products
1
Walker Process Claims
1
Warner Chilcott
1
Warranties
1
White Collar Crimes
1
Wholesale
1
WIPO
1
Wireless Devices
1
Women's Preventable Healthcare Mandates
1
Work Plans
1
Wrongful Death
1
WTO